TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32772460

Group type: EXPERIMENTAL
Intervention: Early arm education on organ donation (mosque-based, religiously tailored education)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Late arm education on organ donation (control educational workshop)
Number of subjects: 158
Study: 35649214

Group type: EXPERIMENTAL
Intervention: Nurse-led telephone-based primary palliative care intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 151
Study: 34605551

Group type: EXPERIMENTAL
Intervention: Novel lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes Prevention Program
Number of subjects: 0
Study: 32183793

Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy (DBT) - weekly individual cognitive behavioural therapy sessions and a 2.5 h skills training group session twice per week for 6 months
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment as usual - weekly individual therapy sessions of 30-45 min with a psychotherapist or social worker
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy (DBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 128
Study: 35732620

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg/d for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32450939

Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT-based guided self-help (CACBT-GSH) intervention (eight sessions, one session per week)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 76
Study: 33563035

Group type: COMPARATOR
Intervention: Traditional weight loss program
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Program including training in providing support
Number of subjects: 94
Study: 33932272

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3) LVAD
Number of subjects: 2200
Study: 36228978

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using methylene blue and IPL (560 to 700 nm, fluence 12 J/cm2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser (10,600 nm, 1.600 mj energy and 0.6 mm density)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 laser and photodynamic therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study: 34925341

Group type: EXPERIMENTAL
Intervention: Vagal Nerve Stimulation (VNS)
Number of subjects: 7
Study: 34436943

Group type: EXPERIMENTAL
Intervention: Written self-disclosure by CWS
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Mother-written disclosure
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Teacher-written disclosure
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control group (no written disclosure)
Number of subjects: 424
Study: 32478024

Group type: EXPERIMENTAL
Intervention: PCGH (physical conditioning group with an extra-session focus on hypertrophy)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PCG (physical conditioning group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: PCGP (physical conditioning group with an extra-session in a shallow pool)
Number of subjects: 48
Study: 34281516

Group type: EXPERIMENTAL
Intervention: Brief advice plus behavioural change guidance carried out by community champions
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Brief advice only
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 1000
Study: 32331806

Group type: EXPERIMENTAL
Intervention: Two-dose MMR vaccination at 9 months and 2.5 years
Number of subjects: 0
Study: 35066508

Group type: EXPERIMENTAL
Intervention: Online 15‐min educational module on obesity, weight bias, stigma, and discrimination
Number of subjects: 3290

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3290
Study: 34018223

Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 35483811

Group type: EXPERIMENTAL
Intervention: Intentional team formation (n = 91)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Randomized team formation (n = 68)
Number of subjects: 159
Study: 33397050

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasonography (POCUS)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard diagnostic strategy (Control)
Number of subjects: 208
Study: 35701778

Group type: EXPERIMENTAL
Intervention: Ninjin'yoeito (NYT) 7.5 g/day along with 100 mg/day iron supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Iron supplementation 100 mg/day
Number of subjects: 30
Study: 33118901

Group type: EXPERIMENTAL
Intervention: SMS intervention for nutrition information delivery
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (IPC) intervention
Number of subjects: 298
Study: 32467034

Group type: EXPERIMENTAL
Intervention: Nebulized N-acetyl cysteine (NAC), 2 ml of 10% NAC nebulized every six hours.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group receiving saline nebulization.
Number of subjects: 60
Study: 36364858

Group type: EXPERIMENTAL
Intervention: Whole-food plant-based diet (PBD)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Omnivorous diet (Control)
Number of subjects: 70
Study: 32827752

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 106

Group type: COMPARATOR
Intervention: Linagliptin 5 mg
Number of subjects: 106
Study: 36415122

Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (100 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (200 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (100 mg) and (200 mg)
Number of subjects: 18
Study: 35656677

Group type: EXPERIMENTAL
Intervention: Denosumab (5 mg/0.2 mL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (injectable sterile water)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 10

Group type: COMPARATOR
Intervention: Denosumab and Control
Number of subjects: 10
Study: 36385718

Group type: EXPERIMENTAL
Intervention: Genetic counselor-led appointment with a communication booklet
Number of subjects: 22

Group type: COMPARATOR
Intervention: Current clinical practice (return of genetic result by a genetic counselor and cardiologist)
Number of subjects: 22
Study: 35225516

Group type: EXPERIMENTAL
Intervention: Endonucleation chop (EC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional crater chop (CC)
Number of subjects: 100
Study: 32074341

Group type: EXPERIMENTAL
Intervention: Conventional transducers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Novel transducers
Number of subjects: 40
Study: 35227112

Group type: EXPERIMENTAL
Intervention: PA Intervention
Number of subjects: 131

Group type: COMPARATOR
Intervention: Wellness Control
Number of subjects: 131
Study: 35675051

Group type: EXPERIMENTAL
Intervention: 1.1% TTP formulation containing retinol, retinyl acetate, and retinyl palmitate for 24 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.02% RA for 24 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1.1% TTP formulation
Number of subjects: 24
Study: 32086591

Group type: EXPERIMENTAL
Intervention: Modified agar plate fecal culture (mAPC)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Standard agar plate culture (sAPC)
Number of subjects: 1076
Study: 35805277

Group type: EXPERIMENTAL
Intervention: High-Volume Training (HVT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard Training Program (Control)
Number of subjects: 28
Study: 32971155

Group type: EXPERIMENTAL
Intervention: Optimum diabetes care including Ramadan-focused education, flash glucose monitoring, dietary advice, and treatment adjustment
Number of subjects: 30
Study: 35380268

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory dietary intervention (six monthly food-preparation workshops and twelve motivational interviewing telephone calls)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 153
Study: 33663549

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization (EMD) group (n = 55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Retrieval‐only control group (n = 55)
Number of subjects: 110
Study: 32673517

Group type: COMPARATOR
Intervention: Propranolol (20 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Abdominal compression (40 mm Hg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Combination of abdominal compression and propranolol
Number of subjects: 18
Study: 35653554

Group type: EXPERIMENTAL
Intervention: Ciprofol (0.4 mg/kg)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Propofol (1.5 mg/kg)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 289

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 289
Study: 32727729

Group type: EXPERIMENTAL
Intervention: Subretinal transplantation of hESC-derived retinal pigment epithelium (RPE) cells
Number of subjects: 3
Study: 32651595

Group type: EXPERIMENTAL
Intervention: 140-kV orthovoltage X-rays
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 6-MV linear accelerator (linac)
Number of subjects: 22
Study: 34297275

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 50
Study: 35486510

Group type: EXPERIMENTAL
Intervention: Tetric N-Ceram Bulk Fill (TBF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tetric-Ceram HB (TBF/V)
Number of subjects: 80
Study: 35739534

Group type: EXPERIMENTAL
Intervention: Intervention group (N=44)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (N=15)
Number of subjects: 59
Study: 32787506

Group type: EXPERIMENTAL
Intervention: FIND intervention (web conferencing to facilitate family participation in care plan meetings)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36249062

Group type: EXPERIMENTAL
Intervention: Irreversible electroporation (IRE)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 152
Study: 33181232

Group type: EXPERIMENTAL
Intervention: Bougie-assisted ETI
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Non-Bougie ETI
Number of subjects: 1227
Study: 33583009

Group type: EXPERIMENTAL
Intervention: Methicillin-sensitive Staphylococcus aureus (MSSA) identified in 21 patients (41.17%).
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Escherichia coli and Staphylococcus epidermidis each found in 4 patients (7.84%).
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Methicillin-resistant Staphylococcus aureus (MRSA) found in 3 patients (5.88%), all >65 years old.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Mortality rate of 7.84% (n = 4), all patients were ≥67 years old, with 75% (3 of 4) being ≥75 years old.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rare infectious agents found in patients with IV drug abuse (Pseudomonas aeruginosa, Staphylococcus hominis, Citrobacter).
Number of subjects: 51
Study: 34191552

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation therapy (VRT) plus modified Epley procedure for 4 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Modified Epley procedure only
Number of subjects: 47
Study: 32462607

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 299

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 299
Study: 36111483

Group type: EXPERIMENTAL
Intervention: Remimazolam Tosilate Sedation with Adjuvant Sufentanil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33686708

Group type: EXPERIMENTAL
Intervention: Spoon forceps
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alligator forceps
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Snake forceps
Number of subjects: 75
Study: 32521309

Group type: EXPERIMENTAL
Intervention: Actionable findings in radiology reports
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Interannotator agreement
Number of subjects: 1000
Study: 36316921

Group type: EXPERIMENTAL
Intervention: Wuwei Fuzheng Yijing formula (WFY)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Levocarnitine oral solution
Number of subjects: 100
Study: 32209700

Group type: COMPARATOR
Intervention: Infancy-onset dietary intervention based on Nordic Nutrition Recommendations, aiming for a dietary fat distribution with a ratio of saturated fatty acids to monounsaturated and polyunsaturated fatty acids of <1:2 and saturated fatty acids intake of <10% of energy intake.
Number of subjects: 2350

Group type: COMPARATOR
Intervention: Achieving the main intervention target of dietary guidelines.
Number of subjects: 2350
Study: 34821431

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 80
Study: 32253392

Group type: EXPERIMENTAL
Intervention: Piezoelectric technique for third molar root extraction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional technique using manual and rotary instruments
Number of subjects: 50
Study: 33377998

Group type: EXPERIMENTAL
Intervention: Computer-tailored print communication (TPC) letters, n = 405
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Telephone motivational interviewing (TMI) sessions, n = 407
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Combined intervention (two TPC letters and two TMI sessions), n = 408
Number of subjects: 1629

Group type: COMPARATOR
Intervention: No intervention (control group), n = 409
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Computer-tailored print communication (TPC) for fruit and vegetable consumption
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Telephone motivational interviewing (TMI) for fruit and vegetable consumption
Number of subjects: 1629
Study: 33106414

Group type: EXPERIMENTAL
Intervention: Training teachers to assess children’s numerical skills every 10 weeks, with adaptive difficulty based on age and skills.
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Training teachers to assess children’s verbal comprehension skills every 10 weeks, with adaptive difficulty based on age and skills.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control classrooms with no specific intervention.
Number of subjects: 49
Study: 35291989

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Propofol (Control)
Number of subjects: 63
Study: 33846516

Group type: EXPERIMENTAL
Intervention: Cluster Sets (CS: n=8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Traditional Sets (TS: n=8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group (CG: n=8)
Number of subjects: 24
Study: 32057960

Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream (1.5% twice daily)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Vehicle (twice daily)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Triamcinolone cream (0.1% twice daily for 4 weeks then vehicle for 4 weeks)
Number of subjects: 307
Study: 35134093

Group type: EXPERIMENTAL
Intervention: Dual-tasking (two in parallel)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Dual-tasking (one as interruption)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Multitasking
Number of subjects: 192

Group type: COMPARATOR
Intervention: Single-tasking
Number of subjects: 192

Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 192
Study: 33229929

Group type: EXPERIMENTAL
Intervention: Low levels of lipoprotein (a) [Lp(a)]
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated levels of lipoprotein (a) [Lp(a)]
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of lipoprotein (a) [Lp(a)]
Number of subjects: 0
Study: 35041780

Group type: EXPERIMENTAL
Intervention: Balanced multielectrolyte solution (BMES)
Number of subjects: 5037

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 5037
Study: 34292846

Group type: EXPERIMENTAL
Intervention: CME module 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CME module 2
Number of subjects: 0
Study: 32678055

Group type: EXPERIMENTAL
Intervention: Core decompression (CD) + bone marrow buffy coat (BBC) grafting
Number of subjects: 43

Group type: COMPARATOR
Intervention: Core decompression (CD)
Number of subjects: 43
Study: 34158140

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 74
Study: 32785583

Group type: EXPERIMENTAL
Intervention: High-status women
Number of subjects: 55
Study: 34582427

Group type: EXPERIMENTAL
Intervention: Continuous EEG (30‐48 hr; n = 182)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Routine EEG (repeated 20‐minute; n = 182)
Number of subjects: 364
Study: 34635771

Group type: EXPERIMENTAL
Intervention: SnMP 3.0 mg/kg
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: SnMP 4.5 mg/kg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (Ctrl)
Number of subjects: 91
Study: 32980788

Group type: EXPERIMENTAL
Intervention: Real-time video counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone counselling
Number of subjects: 0
Study: 35460295

Group type: EXPERIMENTAL
Intervention: Salbutamol (16 mg for 4 days, then 24 mg 1½ h before exercise)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33875485

Group type: EXPERIMENTAL
Intervention: icodec LD
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: icodec NLD
Number of subjects: 154

Group type: COMPARATOR
Intervention: IGlar U100
Number of subjects: 154
Study: 34499218

Group type: EXPERIMENTAL
Intervention: Tooth movement supplemented with micro-osteoperforations (MOPs) (Tr2, n=8)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tooth movement only (Tr1, n=7)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (Unt, n=15)
Number of subjects: 15
Study: 32869587

Group type: EXPERIMENTAL
Intervention: Tiaoli Piwei needling technique (acupuncture for regulating spleen and stomach), once a day for 4 weeks.
Number of subjects: 128

Group type: COMPARATOR
Intervention: Mosapride citrate dispersible tablet 5 mg, orally 3 times a day for 4 weeks.
Number of subjects: 128
Study: 35710339

Group type: EXPERIMENTAL
Intervention: Automated glucose control system
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 105
Study: 33931347

Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy intervention
Number of subjects: 31
Study: 36370146

Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 1163

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 1163
Study: 35598136

Group type: EXPERIMENTAL
Intervention: Neurological disorders in pregnancy (including primary headache, secondary headache, neurological low back pain, epilepsy, cerebrovascular disorders, peripheral neuropathy, other disorders)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (91 subjects without neurological disorders)
Number of subjects: 91
Study: 36282186

Group type: EXPERIMENTAL
Intervention: Alirocumab (15-100 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Evolocumab (21-140 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 36334181

Group type: EXPERIMENTAL
Intervention: Standard care plus preferred music listening
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standard care plus Melomics-Health music listening
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study: 33268345

Group type: EXPERIMENTAL
Intervention: HLA class II matching
Number of subjects: 1133

Group type: COMPARATOR
Intervention: Control group (HLA class II mismatching)
Number of subjects: 1133
Study: 34449939

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 278

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 278
Study: 34154178

Group type: EXPERIMENTAL
Intervention: Randomization of detector roles as a countermeasure against eavesdropping attacks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generalized attack strategy by eavesdropper (Eve).
Number of subjects: 0
Study: 35681986

Group type: EXPERIMENTAL
Intervention: Desk + Program
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Program Only
Number of subjects: 95

Group type: COMPARATOR
Intervention: Desk Only
Number of subjects: 95
Study: 34650017

Group type: EXPERIMENTAL
Intervention: Manual K-file
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: One G rotary file
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: WaveOne Gold Glider
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 40
Study: 36414206

Group type: EXPERIMENTAL
Intervention: digital cognitive behavior therapy (dCBT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 90
Study: 33618146

Group type: EXPERIMENTAL
Intervention: Buddhist walking meditation (BWM) program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Aerobic exercise program
Number of subjects: 48
Study: 34636066

Group type: EXPERIMENTAL
Intervention: Smoke Sense Urbanova app
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Smoke Sense Urbanova Plus app
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 67
Study: 32202265

Group type: EXPERIMENTAL
Intervention: CGly, 800 mg kg‐1
Number of subjects: 32
Study: 35108727

Group type: EXPERIMENTAL
Intervention: Scheduled virus-specific T cells (VSTs)
Number of subjects: 23
Study: 35277322

Group type: EXPERIMENTAL
Intervention: Athero-occlusive disease (AOD) present
Number of subjects: 131

Group type: COMPARATOR
Intervention: No athero-occlusive disease (AOD)
Number of subjects: 131
Study: 33786648

Group type: EXPERIMENTAL
Intervention: Hot Ethanolic Propolis extract
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cold Ethanolic Propolis extract
Number of subjects: 120
Study: 35837991

Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: glimepiride 2 mg
Number of subjects: 23
Study: 34224590

Group type: EXPERIMENTAL
Intervention: Interventions that included an autonomy component
Number of subjects: 2002

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 2002